Bitchute Telegram Feed

Why Are UK Experts Recommending the HPV Vaccine for Seniors Over 60 Years Old?

On September 28, 2019, The Daily Mail published an article titled "Now give every ADULT the cancer-fighting HPV vaccination and save 'thousands of lives', experts demand as evidence shows the jab can slash the cancer risk for grown-ups too." The article states that leading HPV expert and president of the International Papillomavirus Society, Professor Margaret Stanley, OBE, told reporters that there was a spike in the incidence of HPV cancers when people entered their 60s because their immune systems became weaker over time.  She stated: "HPV breaks the usual rules of vaccination. Vaccinating older, infected people will make it less likely that cancers will develop." However, Health Impact News found no evidence to support her claim. In fact, according to our information, if a person is already infected with the HPV virus, getting vaccinated could, in fact, increase, not decrease their chances of getting cancer. In 2018, we reported that according to the research of French oncologist Dr. Gérard Delépine, the HPV vaccine Gardasil was actually associated with an increased rate of cervical cancer among patients. If Dr. Delépine’s research is correct, then if everyone in Britain were to be vaccinated with the HPV vaccine, there is an extremely high possibility that the rates for cervical cancer in Britain could increase.

Read More

Finnish Citizens Conduct Own Vaccine Safety Study and Question Health Authorities Letting 12-Year-Olds Make Own Decisions About HPV Vaccine without Parental Consent

A support group comprised of vaccine-injured and their families in Finland circulated an internet-based questionnaire to find out if there could be an association between vaccinations and healthy children or adolescents/adults falling ill.  Once the results were compiled and analyzed, it was impossible for them to find a medical professional willing to help them get the results published in a peer-reviewed medical journal. They contacted academics from their own country and abroad. All of those contacts agreed that the study has been conducted well and that it deserved to be published, but none of them were willing to co-author the manuscript because of the controversial nature of the topic. In other words, they were afraid of being bullied and losing their position. "How ethical is it to give the HPV-vaccine without informed consent and to advertise it is safe and effective and leave the decision to 12 years old girls?"

Read More

Our Battle after Gardasil: 13 Year Old Girl’s Life Damaged

This story started when my daughter Chiara was 13 years old, now she is 18. She used to be a very good athlete with symptoms from Hashimoto’s thyroiditis with high levels of anti-thyroid peroxidase antibodies. These were already known much before receiving the HPV vaccine. She was really a good athlete and Hashimoto’s did not stop her from participating in the World Championship Karate in Caorle where she had the first place twice. In 2010, she took the brown belt. Apart from Karate interest, Chiara’s other hobbies included painting, singing and practicing all kind of sports. That was Chiara’s profile before Gardasil. Six years have already passed since the Gardasil treatment and the strong headache, dizziness, osteochondritis, Hashimoto’s, articular and abdominal pains are still there. Moreover, she is still under a strict diet that prevents her from taking milk derivatives and food containing gluten. This is my daughter’s story and I wrote it to bring you about the injuries that Gardasil could cause. I hope our experience could help any of you to make the best decision and deeply investigate before subject your son to any HPV vaccine. Above all, I hope Chiara and all the other survivors of new medical conditions after HPV vaccinations find treatments to help them get their normal lives back.

Read More

Government Health Agencies Take Huge Profits from Vaccine Royalties – Gardasil the Top One

The CDC is a major player in the vaccine marketplace, buying half of all childhood vaccines in the U.S. and then selling them to contracted public health agencies through the Vaccines for Children (VFC) Program, which pushes free and low-cost vaccines on indigent children. Over the past three decades, the CDC’s vaccine purchases have increased 15-fold as the average cost of fully vaccinating a child to age 18 rose from $100 to $2192—while vaccine companies have raked in the profits. The agency’s involvement with vaccine manufacturers also extends to patents, licensing agreements and collaboration on projects to develop new vaccines. In fact, the CDC and the National Institutes of Health (NIH) profit handsomely from their ownership or co-ownership with private sector partners of vaccine-related patents. Some of the key technologies underlying the development of the HPV vaccines Gardasil and Cervarix emerged from research patented by the NIH’s National Cancer Institute (NCI), which then licensed the technology to Merck, MedImmune and GlaxoSmithKline. By 2009, HPV licensing had become NIH’s top generator of royalty revenues. Gardasil is “perhaps the leading example of a new form of unconstrained government self-dealing, in arrangements whereby [HHS] can transfer technology to pharmaceutical partners, [and] simultaneously both approve and protect their partners’ technology licenses while also taking a cut of the profits.” It seems doubtful that agencies can remain impartial in the face of these profits.

Read More

25 Reasons to Avoid the Gardasil Vaccine that Never Should Have Been Approved by the FDA

It has been 13 years since the U.S. Food and Drug Administration (FDA) supplied fast-tracked approval for Merck’s Gardasil vaccine—promoted for the prevention of cervical cancer and other conditions attributed to four types of human papillomavirus (HPV). The agency initially licensed Gardasil solely for 9- to 26-year-old girls and women, but subsequent FDA decisions now enable Merck to market Gardasil’s successor—the nine-valent Gardasil 9 vaccine—to a much broader age range—9 to 45 years—and to both males and females. As a result of Gardasil’s expanding markets not just in the U.S. but internationally, the blockbuster HPV vaccine has become Merck’s third highest-grossing product, bringing in annual global revenues of about $2.3 billion. However, Gardasil’s safety record has been nothing short of disastrous. Children’s Health Defense and Robert F. Kennedy, Jr. have just produced a video detailing the many problems with the development and safety of Gardasil. What follow are 25 key facts about Gardasil/Gardasil 9, including facts about the HPV vaccines’ clinical trials and adverse outcomes observed ever since Merck, public health officials and legislators aggressively foisted the vaccines on an unsuspecting public.

Read More

New Research: High HPV Cancer Rates Linked to High Gardasil Vaccination Rates – “Exactly the Opposite of what we Expected”

Last year (2018) we reported on the research of French oncologist Dr. Gérard Delépine, who published an analysis of the HPV vaccine Gardasil showing how increased rates of Gardasil vaccinations are actually correlated with a higher rate of cervical cancer. Now, researchers at the University of South Alabama are observing the same link of increased Gardasil vaccination rates with an increased rate of HPV related cervical cancers in Alabama. The researchers and medical doctors commented that this was a "surprising discovery" and that it was "exactly the opposite of what we expected." It is highly unlikely this will be reported in any of the corporate-sponsored "mainstream" media sources.

Read More

Gardasil Vaccine on Trial: Attorney Robert F. Kennedy, Jr. Exposes Merck Corruption

Robert F. Kennedy, Jr. is one of the attorneys in the Jennifer Robi vs. Merck and Kaiser Permanente fraud case currently being litigated in Los Angeles Superior Court. This must-watch video, referencing much of the science presented as evidence during the trial, details the many problems with the development and safety of Merck’s third-highest grossing product, Gardasil. Children’s Health Defense (CHD) and Robert F. Kennedy, Jr., CHD’s Chairman and Chief Legal Counsel, ask that you watch and share this video so that you, and others, may make an informed decision of whether or not to give your child, boy or girl, a Gardasil vaccine. It can also be a useful tool for pediatricians who are trying to understand how this vaccine, that is actually causing health problems with young people, could have been approved by FDA and then recommended by CDC. The video is full of jaw-dropping facts about Gardasil and the clinical trials leading up to its release upon an unsuspecting public.

Read More

Merck Sees “Unprecedented” Growth in Gardasil Vaccine – Over $3 Billion in Sales in 2018 with Expansion into China

Vaccine manufacturer Merck & Co. has reported earnings from its Gardasil HPV vaccine for 2018 at $3.15 billion, far above the previous year sales of $2.31 billion. First quart of 2019 sales of the Gardasil vaccine have soared 31% to $838 million for the first three months of 2019. Executives from the company have stated that these sales of the Gardasil vaccine are "unprecedented," and the company plans to spend over $1 billion to expand its Gardasil vaccine production. Much of this growth of the Gardasil vaccine market is due to Merck's expansion into China. While many other countries, like Japan, are pulling back on their recommendations for the Gardasil vaccines due to the sheer volume of reported Gardasil vaccine injuries, and the resulting lawsuits in those countries against Merck and its distributors, something that is not possible in the United States due to the legal immunity vaccine makers enjoy, China is running full speed ahead to introduce the Gardasil vaccine to its population.

Read More

States Move to Mandate Deadly HPV Gardasil Vaccine for Children

Pharmaceutical giant Merck's political influence is now reaching beyond the CDC and federal government, and moving into state legislatures as several states have introduced bills to mandate Merck's Gardasil HPV vaccine for children. The HPV vaccine, which only applies to sexually active people, is not currently part of the CDC vaccine schedule, therefore separate legislation is needed to compel children to receive it. What is withheld from the public is the fact that Merck is fighting fraud cases in U.S. courts and multiple other lawsuits around the world concerning the Gardasil vaccine, as the vaccine continues to kill and injure, primarily teenage girls. Here are the states currently considering new legislation to mandate the deadly Gardasil vaccine against parental choice.

Read More

Will New FDA Approval of Gardasil Vaccine for Adults Lead to Mandatory Gardasil Vaccination?

After the U.S. Food and Drug Administration’s (FDA) approved Merck’s HPV-9 Gardasil vaccine for use in adults age 27 to 45 in 2018, the Centers for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) of the Department of Health and Human Services (HHS) is evaluating whether to expand their current HPV vaccine recommendation to include this new age group. ACIP’s current recommendation is that boys and girls ages 9 through 15 should get two-doses of HPV-9. The “catch-up” vaccine schedule is a three- dose series for females above age 15 through age 27 and males above 15 years of age to 21 years of age, if not previously vaccinated with HPV vaccine. Should ACIP expand their recommendations for use of HPV-9 vaccine in the newly approved age group, the CDC won’t be alone in the push to increase the use of the HPV vaccine by children and adults in the U.S. During the September meeting of the National Vaccine Advisory Committee (NVAC), a federal advisory committee that makes recommendations to the National Vaccine Program Office (NVPO), the HHS Assistant Secretary ADM Brett Giroir M.D. emphasized that HHS supported the NVAC’s HPV vaccine recommendations published in June 2018. Dr. Giroir stated that increasing HPV vaccination in America would be a focus for HHS in 2019. The federal government’s focus on increasing the use recommendations for the HPV vaccine may result in a renewed effort by state legislators to introduce legislation in many states to mandate HPV vaccine for school entry.

Read More